Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Buy
57
FLS Quote, Financials, Valuation and Earnings
Last price:
$50.59
Seasonality move
:
8.05%
Day range:
$49.68 - $50.83
52-week range:
$43.66 - $65.08
Dividend yield:
1.66%
P/E ratio:
23.63x
P/S ratio:
1.47x
P/B ratio:
3.32x
Volume:
1.9M
Avg. volume:
1.8M
1-year change:
10.05%
Market cap:
$6.7B
Revenue:
$4.6B
EPS (TTM):
$2.14
Analysts' Opinion
-
Consensus RatingFlowserve has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $71.50, Flowserve has an estimated upside of 41.39% from its current price of $50.57.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $64.00 representing 100% downside risk from its current price of $50.57.
Fair Value
-
According to the consensus of 10 analysts, Flowserve has 41.39% upside to fair value with a price target of $71.50 per share.
FLS vs. S&P 500
-
Over the past 5 trading days, Flowserve has overperformed the S&P 500 by 2.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Flowserve does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Flowserve has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Flowserve reported revenues of $1.2B.
Earnings Growth
-
Flowserve has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Flowserve reported earnings per share of $0.59.
Enterprise value:
7.5B
EV / Invested capital:
2.12x
Price / LTM sales:
1.47x
EV / EBIT:
16.54x
EV / Revenue:
1.65x
PEG ratio (5yr expected):
0.46x
EV / Free cash flow:
21.89x
Price / Operating cash flow:
19.44x
Enterprise value / EBITDA:
13.93x
Gross Profit (TTM):
$1.4B
Return On Assets:
5.4%
Net Income Margin (TTM):
6.2%
Return On Equity:
13.94%
Return On Invested Capital:
8.51%
Operating Margin:
10.18%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.6B | $4.3B | $4.6B | $1.2B | $1.2B | |
| Gross Profit | $994.3M | $1.3B | $1.4B | $339.5M | $372.1M | |
| Operating Income | $178.8M | $315.7M | $456.2M | $104.8M | $120.1M | |
| EBITDA | $291.6M | $374.4M | $541.1M | $109M | $148.5M | |
| Diluted EPS | $1.43 | $1.41 | $2.14 | $0.47 | $0.59 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $2.4B | $2.5B | $2.7B | $2.9B | |
| Total Assets | $5.3B | $4.7B | $4.8B | $5.1B | $5.5B | |
| Current Liabilities | $1.1B | $1.1B | $1.2B | $1.4B | $1.5B | |
| Total Liabilities | $3.6B | $2.9B | $2.9B | $3.1B | $3.4B | |
| Total Equity | $1.8B | $1.8B | $1.9B | $2B | $2.1B | |
| Total Debt | $1.7B | $1.3B | $1.3B | $1.2B | $1.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$40M | $325.8M | $425.3M | $194.6M | $197.3M | |
| Cash From Investing | -$6.1M | -$68.6M | -$387.2M | -$20.2M | -$333.1M | |
| Cash From Financing | -$150M | -$153M | $117.5M | -$120.9M | $224.9M | |
| Free Cash Flow | -$116.3M | $258.4M | $344.3M | $174.8M | $168.5M | |
FLS
Sector
Market Cap
$6.7B
$618.1M
Price % of 52-Week High
77.71%
74.1%
Dividend Yield
1.66%
0%
Shareholder Yield
1.26%
2.42%
1-Year Price Total Return
10.05%
-6.88%
Beta (5-Year)
1.426
0.889
Dividend yield:
1.66%
Annualized payout:
$0.84
Payout ratio:
39.06%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$49.85
200-day SMA
Sell
Level
$53.55
Bollinger Bands (100)
Sell
Level
53.67 - 62.61
Chaikin Money Flow
Buy
Level
175.5M
20-day SMA
Sell
Level
$51.47
Relative Strength Index (RSI14)
Sell
Level
41.74
ADX Line
Sell
Level
36.85
Williams %R
Neutral
Level
-20.8981
50-day SMA
Sell
Level
$57.73
MACD (12, 26)
Sell
Level
-2.33
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
130.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7516)
Sell
CA Score
(Annual)
Level (-0.3297)
Buy
Beneish M-Score
(Annual)
Level (-2.5278)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1511)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
Stock Forecast FAQ
In the current month, FLS has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The FLS average analyst price target in the past 3 months is $71.50.
-
Where Will Flowserve Stock Be In 1 Year?
According to analysts, the consensus estimate is that Flowserve share price will rise to $71.50 per share over the next 12 months.
-
What Do Analysts Say About Flowserve?
Analysts are divided on their view about Flowserve share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Flowserve is a Sell and believe this share price will drop from its current level to $64.00.
-
What Is Flowserve's Price Target?
The price target for Flowserve over the next 1-year time period is forecast to be $71.50 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is FLS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Flowserve is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of FLS?
You can purchase shares of Flowserve via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Flowserve shares.
-
What Is The Flowserve Share Price Today?
Flowserve was last trading at $50.59 per share. This represents the most recent stock quote for Flowserve. Yesterday, Flowserve closed at $50.57 per share.
-
How To Buy Flowserve Stock Online?
In order to purchase Flowserve stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
